RT Journal Article
SR Electronic
T1 Pooling RT-PCR or NGS samples has the potential to cost-effectively generate estimates of COVID-19 prevalence in resource limited environments
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.04.03.20051995
DO 10.1101/2020.04.03.20051995
A1 Krishna R Narayanan
A1 Isabel Frost
A1 Anoosheh Heidarzadeh
A1 Katie K Tseng
A1 Sayantan Banerjee
A1 Jacob John
A1 Ramanan Laxminarayan
YR 2020
UL http://medrxiv.org/content/early/2020/04/06/2020.04.03.20051995.abstract
AB Background COVID-19 originated in China and has quickly spread worldwide causing a pandemic. Countries need rapid data on the prevalence of the virus in communities to enable rapid containment. However, the equipment, human and laboratory resources required for conducting individual RT-PCR is prohibitive. One technique to reduce the number of tests required is the pooling of samples for analysis by RT-PCR prior to testing.Methods We conducted a mathematical analysis of pooling strategies for infection rate classification using group testing and for the identification of individuals by testing pooled clusters of samples.Findings On the basis of the proposed pooled testing strategy we calculate the probability of false alarm, the probability of detection, and the average number of tests required as a function of the pool size. We find that when the sample size is 256, using a maximum pool size of 64, with only 7.3 tests on average, we can distinguish between prevalences of 1% and 5% with a probability of detection of 95% and probability of false alarm of 4%.Interpretation The pooling of RT-PCR samples is a cost-effective technique for providing much-needed course-grained data on the prevalence of COVID-19. This is a powerful tool in providing countries with information that can facilitate a response to the pandemic that is evidence-based and saves the most lives possible with the resources available.Funding Bill & Melinda Gates FoundationAuthors contributions RL and KRN conceived the study. IF, KT, KRN, SB and RL all contributed to the writing of the manuscript and AH and JJ provided comments. KRN and AH conducted the analysis and designed the figures.Evidence before this study The pooling of RT-PCR samples has been shown to be effective in screening for HIV, Chlamydia, Malaria, and influenza, among other pathogens in human health. In agriculture, this method has been used to assess the prevalence of many pathogens, including Dichelobacter nodosus, which causes footrot in sheep, postweaning multisystemic wasting syndrome, and antibiotic resistance in swine feces, in addition to the identification of coronaviruses in multiple bat species. In relation to the current pandemic, researchers in multiple countries have begun to employ this technique to investigate samples for COVID-19.Added value of this study Given recent interest in this topic, this study provides a mathematical analysis of infection rate classification using group testing and calculates the probability of false alarm, the probability of detection, and the average number of tests required as a function of the pool size. In addition the identification of individuals by pooled cluster testing is evaluated.Implications of all the available evidence This research suggests the pooling of RT-PCR samples for testing can provide a cheap and effective way of gathering much needed data on the prevalence of COVID-19 and identifying infected individuals in the community, where it may be infeasible to carry out a high number of tests. This will enable countries to use stretched resources in the most appropriate way possible, providing valuable data that can inform an evidence-based response to the pandemic.Competing Interest StatementThe authors have declared no competing interest.Funding StatementBill & Melinda Gates FoundationAuthor DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesN/A